2.Hepatic Arterioportal Shunts: Dynamic CT and MR Features.
Byung Ihn CHOI ; Kyoung Ho LEE ; Joon Koo HAN ; Jeong Min LEE
Korean Journal of Radiology 2002;3(1):1-15
With the increased temporal resolution available in dynamic computed tomography (CT) and magnetic resonance imaging (MRI), hepatic arterioportal shunts are now more frequently encountered than in the past. The condition occurs in various hepatic diseases in which portal or hepatic venous flow is compromised. The underlying mechanism and the degree of shunt affect its appearance at dynamic imaging. The dynamic CT and MRI findings have been summarized as early enhancement of peripheral portal veins, and wedge-shaped transient parenchymal enhancement during the hepatic arterial phase. Recognition of arterioportal shunt can suggest the presence of a previously unsuspected disorder and avoids false-positive diagnosis or overestimation of a hepatic disease. Familiarity with the pathophysiology of arterioportal shunt also allows investigation of the hepatic hemodynamic changes occurring in various hepatic diseases.
Arteriovenous Fistula/*diagnosis/etiology/physiopathology
;
Carcinoma, Hepatocellular/complications
;
Chemoembolization, Therapeutic/adverse effects
;
*Hepatic Artery
;
Human
;
Liver Circulation/physiology
;
Liver Diseases/complications
;
Liver Neoplasms/complications
;
*Magnetic Resonance Imaging
;
Portal System/physiology
;
*Portal Vein
;
*Tomography, X-Ray Computed
3.Effects of salvianolic acid B and diammonium glycyrrhizinate on portal pressure in rats.
Hang ZHOU ; Si-Xuan WANG ; Tao ZHANG
Chinese Journal of Integrated Traditional and Western Medicine 2010;30(10):1084-1086
OBJECTIVETo study the relaxant effects of glycyrrhizinate and salvianolic acid B on rat portal vein in vitro.
METHODSHealthy female Wistar rats were canalized from hepatic artery, portal vein and hepatic vein in vitro. Remained blood in liver was eliminated with heparinized Krebs-Henseleit solution through hepatic artery, then the liver was isolated under infusing manner. Being constricted with phenylephrine and relaxed with acetylcholine, and infused with glycyrrhizinate or salvianolic acid B, the portal pressures of infused rat livers were consistently monitored by BL-420S physiological experiment system. The median effective concentration (EC50) of the two agents were analyzed with non-linear various slope regression using Prism-4 software.
RESULTSEC50 of glycyrrhizinate in relaxing the phenylephrine-contracted portal was 1.5556 x 10(-9) mol/L, suggesting one of the mechanism of action of diammonium glycyrhizinate for the treatment of portal hypertension was direct relaxation. Salvianolic acid B showed constrictive action on the phenylephrine-retracted portal vein, the EC50 was 1.4639 x 10(-9) mol/L, indicating that its indirect control action was took part in the portal hypertension therapy synergistically.
CONCLUSIONUnder the mode with both controlled-velocity and monitored pressure, glycyrrhizinate showed relaxation and salvianolic acid B showed constriction on portal pressure in vitro.
Animals ; Benzofurans ; pharmacology ; Blood Pressure ; drug effects ; Female ; Glycyrrhizic Acid ; pharmacology ; Hypertension, Portal ; physiopathology ; Phenylephrine ; pharmacology ; Portal Vein ; physiology ; Rats ; Rats, Wistar ; Vasoconstrictor Agents ; pharmacology ; Vasodilator Agents ; pharmacology ; Vasomotor System ; drug effects